As I recall, you have been employed by Maximus. If this is still the case then I think it should be disclosed when you're promoting them in this manner. I'm not questioning your objectivity, and I have also had favorable things to say about Maximus. However, disclosing the affiliation is the right thing to do, so that readers can consider this possible source of bias.
@guil70: I see you have been on Clomid, which is basically enclomiphene plus estrogen (zuclomiphene) — roughly half and half. So in reality you already have some experience with the drug. It's a simple matter to look at
one of the clinical trials for enclomiphene to see the results of administering 6.25, 12.5 or 25 mg per day of the drug. Other things to bear in mind: Zuclomiphene has a very long half-life, so it may persist for more than a month or two after stopping Clomid. The loss of zuclomiphene is usually a positive, however, there are occasional reports of men doing better with Clomid.